In a regulatory filing, Aerovate Therapeutics disclosed that its director Rajeev Shah of RA Capital bought 928K shares of common stock on June 17th in a total transaction size of $1.55M. Shares of Aerovate Therapeutics are up 11.6% afterhours at $1.63.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTE:
- Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls
- Aerovate Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
- Aerovate Therapeutics downgraded to Hold from Buy at TD Cowen
- Aerovate Therapeutics downgraded to In Line from Outperform at Evercore ISI
- Aerovate Therapeutics downgraded to Neutral from Buy at Guggenheim